Eligibility criteria
Condition
Hemophilia A
Sex
Females and Males
Age
0 +
Inclusion criteria
Show details
- Patients who were or are enrolled in Study CTN 93-R833-0XX/C9741-28, and have been
treated with ReFacto® during this study are eligible for participation.
- The patient (or legal guardian) must be willing to give written informed consent
before any study-related procedures are performed.
- A blood sample will be collected from each patient for the purpose of this study and
will be analyzed at one or both of the designated central laboratories.
Exclusion criteria
Show details
- Any condition which, in the investigator's opinion, places the patient at undue risk.